Abstract
It has become apparent over the past few decades that several factors can determine lethal or sublethal alterations of cardiovascular system cell function such as inflammatory reaction products, peptides and hormones. In turn, the loss of cellular components from the blood vessels wall and the heart tissue contributes to the development of cardiovascular diseases (CVD). Hence, in the recent years, the efforts of several research groups have specifically been devoted to deeply investigate the implication of the main forms of cell injury, necrosis, apoptosis and autophagy, in the development of cardiac and blood vessel alterations associated with human diseases. Furthermore, several lines of evidence demonstrate that CVD clearly display significant gender differences in terms of onset, progression and outcome. Cardiovascular cells contain functional estrogen and androgen receptors and are targets for sex hormone action, which can influence many physiological and pathological processes, including vascular and myocardial cell homeostasis. However, hormones are important but not unique actors in this issue, further genetic and epigenetic determinants being involved. This review focuses on recent studies on the effects of gender differences, including sex hormones, on cardiac and vascular cell injury and death and their influence in determining atherosclerosis, heart failure and other main human CVD.
Keywords: Gender, cell death, apoptosis, cardiovascular, sex hormones, cardiomyocytes, endothelial cells, vascular smooth muscle cells, lethal, implication, necrosis, autophagy, epigenetic, hypertension, vasculopathy, cathepsins, myocarditis, extravasation, autophagosomes, abrogation, Depolarization, cytoprotective
Current Pharmaceutical Design
Title: Gender Specific Aspects of Cell Death in the Cardiovascular System
Volume: 17 Issue: 11
Author(s): Marina Pierdominici, Elena Ortona, Flavia Franconi, Massimiliano Caprio, Elisabetta Straface and Walter Malorni
Affiliation:
Keywords: Gender, cell death, apoptosis, cardiovascular, sex hormones, cardiomyocytes, endothelial cells, vascular smooth muscle cells, lethal, implication, necrosis, autophagy, epigenetic, hypertension, vasculopathy, cathepsins, myocarditis, extravasation, autophagosomes, abrogation, Depolarization, cytoprotective
Abstract: It has become apparent over the past few decades that several factors can determine lethal or sublethal alterations of cardiovascular system cell function such as inflammatory reaction products, peptides and hormones. In turn, the loss of cellular components from the blood vessels wall and the heart tissue contributes to the development of cardiovascular diseases (CVD). Hence, in the recent years, the efforts of several research groups have specifically been devoted to deeply investigate the implication of the main forms of cell injury, necrosis, apoptosis and autophagy, in the development of cardiac and blood vessel alterations associated with human diseases. Furthermore, several lines of evidence demonstrate that CVD clearly display significant gender differences in terms of onset, progression and outcome. Cardiovascular cells contain functional estrogen and androgen receptors and are targets for sex hormone action, which can influence many physiological and pathological processes, including vascular and myocardial cell homeostasis. However, hormones are important but not unique actors in this issue, further genetic and epigenetic determinants being involved. This review focuses on recent studies on the effects of gender differences, including sex hormones, on cardiac and vascular cell injury and death and their influence in determining atherosclerosis, heart failure and other main human CVD.
Export Options
About this article
Cite this article as:
Pierdominici Marina, Ortona Elena, Franconi Flavia, Caprio Massimiliano, Straface Elisabetta and Malorni Walter, Gender Specific Aspects of Cell Death in the Cardiovascular System, Current Pharmaceutical Design 2011; 17 (11) . https://dx.doi.org/10.2174/138161211795656891
DOI https://dx.doi.org/10.2174/138161211795656891 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Apoptosis Induction by Ultrasound and Microbubble Mediated Drug Delivery and Gene Therapy
Current Molecular Medicine Monoclonal Antibodies in the Management of Solid Tumors
Current Topics in Medicinal Chemistry Selective Divalent Copper Chelation for the Treatment of Diabetes Mellitus
Current Medicinal Chemistry “European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Current Vascular Pharmacology Histone Deacetylase Inhibitors: Molecular and Biological Activity as a Premise to Clinical Application
Current Drug Metabolism The Role of COX-2 in Acute Pain and the Use of Selective COX-2 Inhibitors for Acute Pain Relief
Current Pharmaceutical Design Understanding Effects of Psychological Stress on Physiology and Disease Through Human Stressome - An Integral Algorithm
Current Bioinformatics Domperidone and Long QT Syndrome
Current Drug Safety Pharmacological Properties and Therapeutic Possibilities for Drugs Acting Upon Endocannabinoid Receptors
Current Drug Targets - CNS & Neurological Disorders Therapy Against Ischemic Injury
Current Pharmaceutical Design Cardiovascular Risk Factors: Does Sex Matter?
Current Vascular Pharmacology Identification of Novel NaV1.7 Antagonists Using High Throughput Screening Platforms
Combinatorial Chemistry & High Throughput Screening Venous Thromboembolism in Patients with Heart Failure: In-hospital and Chronic Use of Anti-coagulants for Prevention
Recent Patents on Cardiovascular Drug Discovery Cytotoxicity and Toxicity to Animals and Humans of Ribosome-Inactivating Proteins
Mini-Reviews in Medicinal Chemistry Integrin α4β7 Antagonists: Activities, Mechanisms of Action and Therapeutic Prospects
Current Immunology Reviews (Discontinued) Pathological Features of Antibody-Mediated Rejection
Current Drug Targets - Cardiovascular & Hematological Disorders Material-Based Engineering Strategies for Cardiac Regeneration
Current Pharmaceutical Design Angiotensin Converting Enzyme-2: A Doorway for SARS-CoV-2
Coronaviruses Emerging Role of Stem Cells - Derived Exosomes as Valuable Tools for Cardiovascular Therapy
Current Stem Cell Research & Therapy Eplerenone, a New Selective Aldosterone Blocker
Current Pharmaceutical Design